Gretex Corporate Services Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 29, 2025, 1:36 pm

Quick Insight

Gretex Corporate Services Ltd, with a share price of 265 and a market capitalization of 600 Cr., presents a mixed financial performance as indicated by a low ROE of 0.86% and ROCE of 2.70%. The company's OPM stands at 7.83%, reflecting some operational efficiency. However, the high P/BV ratio of 3.34x suggests the stock may be overvalued based on its book value. With reserves of 181 Cr. and borrowings at ₹11Cr, Gretex seems to have a stable financial footing. The comfortable ICR of 14.78x indicates the company's ability to meet its interest obligations. Investors should closely monitor Gretex's profitability and valuation metrics to make informed investment decisions.

Competitors of Gretex Corporate Services Ltd

All Competitor Stocks of Gretex Corporate Services Ltd

Quarterly Result

Last Updated: August 19, 2025, 5:45 pm

Below is a detailed analysis of the quarterly data for Gretex Corporate Services Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 21.98 Cr.. The value appears to be declining and may need further review. It has decreased from 59.87 Cr. (Mar 2025) to 21.98 Cr., marking a decrease of 37.89 Cr..
• For Expenses, as of Jun 2025, the value is 20.26 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 72.14 Cr. (Mar 2025) to 20.26 Cr., marking a decrease of 51.88 Cr..
• For Operating Profit, as of Jun 2025, the value is 1.72 Cr.. The value appears strong and on an upward trend. It has increased from -12.27 Cr. (Mar 2025) to 1.72 Cr., marking an increase of 13.99 Cr..
• For OPM %, as of Jun 2025, the value is 7.83%. The value appears strong and on an upward trend. It has increased from -20.49% (Mar 2025) to 7.83%, marking an increase of 28.32%.
• For Other Income, as of Jun 2025, the value is 0.68 Cr.. The value appears strong and on an upward trend. It has increased from -10.55 Cr. (Mar 2025) to 0.68 Cr., marking an increase of 11.23 Cr..
• For Interest, as of Jun 2025, the value is 0.24 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.19 Cr. (Mar 2025) to 0.24 Cr., marking an increase of 0.05 Cr..
• For Depreciation, as of Jun 2025, the value is 0.66 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.68 Cr. (Mar 2025) to 0.66 Cr., marking a decrease of 0.02 Cr..
• For Profit before tax, as of Jun 2025, the value is 1.50 Cr.. The value appears strong and on an upward trend. It has increased from -23.69 Cr. (Mar 2025) to 1.50 Cr., marking an increase of 25.19 Cr..
• For Tax %, as of Jun 2025, the value is 36.67%. The value appears to be increasing, which may not be favorable. It has increased from -11.36% (Mar 2025) to 36.67%, marking an increase of 48.03%.
• For Net Profit, as of Jun 2025, the value is 0.96 Cr.. The value appears strong and on an upward trend. It has increased from -21.00 Cr. (Mar 2025) to 0.96 Cr., marking an increase of 21.96 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.34. The value appears strong and on an upward trend. It has increased from -7.57 (Mar 2025) to 0.34, marking an increase of 7.91.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 23, 2025, 1:00 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:10 pm

Below is a detailed analysis of the balance sheet data for Gretex Corporate Services Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 12.00 Cr..
• For Reserves, as of Mar 2025, the value is 181.00 Cr.. The value appears strong and on an upward trend. It has increased from 97.00 Cr. (Mar 2024) to 181.00 Cr., marking an increase of 84.00 Cr..
• For Borrowings, as of Mar 2025, the value is 11.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 4.00 Cr. (Mar 2024) to 11.00 Cr., marking an increase of 7.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 66.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 63.00 Cr. (Mar 2024) to 66.00 Cr., marking an increase of 3.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 270.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 177.00 Cr. (Mar 2024) to 270.00 Cr., marking an increase of 93.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 41.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 41.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 129.00 Cr.. The value appears strong and on an upward trend. It has increased from 50.00 Cr. (Mar 2024) to 129.00 Cr., marking an increase of 79.00 Cr..
• For Other Assets, as of Mar 2025, the value is 100.00 Cr.. The value appears strong and on an upward trend. It has increased from 86.00 Cr. (Mar 2024) to 100.00 Cr., marking an increase of 14.00 Cr..
• For Total Assets, as of Mar 2025, the value is 270.00 Cr.. The value appears strong and on an upward trend. It has increased from 177.00 Cr. (Mar 2024) to 270.00 Cr., marking an increase of 93.00 Cr..

Notably, the Reserves (181.00 Cr.) exceed the Borrowings (11.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Key Financial Ratios

After reviewing the key financial ratios for Gretex Corporate Services Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 1.11. This value is below the healthy minimum of 5. It has decreased from 24.84 (Mar 24) to 1.11, marking a decrease of 23.73.
• For Diluted EPS (Rs.), as of Mar 25, the value is 1.09. This value is below the healthy minimum of 5. It has decreased from 24.84 (Mar 24) to 1.09, marking a decrease of 23.75.
• For Cash EPS (Rs.), as of Mar 25, the value is 3.74. This value is within the healthy range. It has decreased from 31.97 (Mar 24) to 3.74, marking a decrease of 28.23.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 162.21. It has increased from 129.84 (Mar 24) to 162.21, marking an increase of 32.37.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 162.21. It has increased from 129.84 (Mar 24) to 162.21, marking an increase of 32.37.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 217.25. It has increased from 94.65 (Mar 24) to 217.25, marking an increase of 122.60.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 6.91. This value is within the healthy range. It has decreased from 42.03 (Mar 24) to 6.91, marking a decrease of 35.12.
• For PBIT / Share (Rs.), as of Mar 25, the value is 4.69. This value is within the healthy range. It has decreased from 40.64 (Mar 24) to 4.69, marking a decrease of 35.95.
• For PBT / Share (Rs.), as of Mar 25, the value is 4.23. This value is within the healthy range. It has decreased from 39.70 (Mar 24) to 4.23, marking a decrease of 35.47.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 1.52. This value is below the healthy minimum of 2. It has decreased from 30.59 (Mar 24) to 1.52, marking a decrease of 29.07.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 1.09. This value is below the healthy minimum of 2. It has decreased from 23.58 (Mar 24) to 1.09, marking a decrease of 22.49.
• For PBDIT Margin (%), as of Mar 25, the value is 3.18. This value is below the healthy minimum of 10. It has decreased from 44.40 (Mar 24) to 3.18, marking a decrease of 41.22.
• For PBIT Margin (%), as of Mar 25, the value is 2.16. This value is below the healthy minimum of 10. It has decreased from 42.93 (Mar 24) to 2.16, marking a decrease of 40.77.
• For PBT Margin (%), as of Mar 25, the value is 1.94. This value is below the healthy minimum of 10. It has decreased from 41.94 (Mar 24) to 1.94, marking a decrease of 40.00.
• For Net Profit Margin (%), as of Mar 25, the value is 0.70. This value is below the healthy minimum of 5. It has decreased from 32.31 (Mar 24) to 0.70, marking a decrease of 31.61.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 0.50. This value is below the healthy minimum of 8. It has decreased from 24.91 (Mar 24) to 0.50, marking a decrease of 24.41.
• For Return on Networth / Equity (%), as of Mar 25, the value is 0.67. This value is below the healthy minimum of 15. It has decreased from 24.97 (Mar 24) to 0.67, marking a decrease of 24.30.
• For Return on Capital Employeed (%), as of Mar 25, the value is 2.12. This value is below the healthy minimum of 10. It has decreased from 29.36 (Mar 24) to 2.12, marking a decrease of 27.24.
• For Return On Assets (%), as of Mar 25, the value is 0.48. This value is below the healthy minimum of 5. It has decreased from 15.38 (Mar 24) to 0.48, marking a decrease of 14.90.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.02. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 0.02, marking an increase of 0.02.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.16. It has increased from 1.00 (Mar 24) to 1.16, marking an increase of 0.16.
• For Current Ratio (X), as of Mar 25, the value is 12.74. This value exceeds the healthy maximum of 3. It has increased from 4.99 (Mar 24) to 12.74, marking an increase of 7.75.
• For Quick Ratio (X), as of Mar 25, the value is 3.74. This value exceeds the healthy maximum of 2. It has increased from 2.01 (Mar 24) to 3.74, marking an increase of 1.73.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 3.15 (Mar 24) to 0.00, marking a decrease of 3.15.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 2.98 (Mar 24) to 0.00, marking a decrease of 2.98.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 96.85 (Mar 24) to 0.00, marking a decrease of 96.85.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 97.02 (Mar 24) to 0.00, marking a decrease of 97.02.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 14.78. This value is within the healthy range. It has decreased from 274.67 (Mar 24) to 14.78, marking a decrease of 259.89.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.26. This value is within the healthy range. It has decreased from 206.03 (Mar 24) to 4.26, marking a decrease of 201.77.
• For Enterprise Value (Cr.), as of Mar 25, the value is 692.03. It has increased from 442.44 (Mar 24) to 692.03, marking an increase of 249.59.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.67. This value is within the healthy range. It has decreased from 4.06 (Mar 24) to 2.67, marking a decrease of 1.39.
• For EV / EBITDA (X), as of Mar 25, the value is 84.04. This value exceeds the healthy maximum of 15. It has increased from 9.14 (Mar 24) to 84.04, marking an increase of 74.90.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.49. This value is within the healthy range. It has decreased from 3.88 (Mar 24) to 2.49, marking a decrease of 1.39.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 96.84 (Mar 24) to 0.00, marking a decrease of 96.84.
• For Price / BV (X), as of Mar 25, the value is 3.34. This value exceeds the healthy maximum of 3. It has decreased from 3.89 (Mar 24) to 3.34, marking a decrease of 0.55.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.49. This value is within the healthy range. It has decreased from 3.88 (Mar 24) to 2.49, marking a decrease of 1.39.
• For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.06 (Mar 24) to 0.00, marking a decrease of 0.06.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness